2025 has been a year of real progress for P2i – a period where long-term relationships came to fruition, new technologies moved from development into deployment, and our global footprint continued to grow. Below is a look back at the key moments that shaped the business this year and the foundations they’ve set for 2026.
Jolt Capital Takes a Controlling Stake in P2i
The most significant milestone this year was Jolt Capital’s decision to take a controlling stake in P2i, supported by an initial €8 million investment. After several years of close collaboration, this formal partnership marks a turning point for the company. For Jolt, P2i is a clear fit with their deeptech investment philosophy – a proven, sustainable technology with global relevance and strong growth potential.
For us, the investment brings both strategic backing and financial strength at a pivotal time. With more than a billion devices already protected using our plasma-enhanced thin film deposition process, the backing of Jolt’s experienced team reinforces our ability to scale, diversify, and accelerate innovation. As Jolt’s first UK investment, it also signals their confidence in the direction we’re heading and the opportunity ahead in protective nanotechnology across electronics, automotive, and medical sectors.
Launching Our Liquid Barrier Coatings Offering
Another major highlight was the launch of our Liquid Barrier Coatings (LBC) – a fully defined, production-ready solution that removes the uncertainty typically associated with coating qualification. By reviewing a customer’s Qualification Test Plan and CAD/STEP files, we can now recommend the best coating first time, rather than relying on trial-and-error testing.
These ultra-thin coatings integrate seamlessly into existing manufacturing lines – spray, dip, jet, no vacuum, no cure cycles – and deliver proven protection from IPX3 through to IPX8. They’re flexible across substrates, fast to apply, and built to keep pace with real-world production demands. For teams looking to strengthen device reliability without slowing down throughput, the LBC range offers a practical, highly optimised route forward. If you’d like to explore what this could look like for your own products, our engineers are always on hand to talk through the details.
Advancing PFOA-Free and PFAS-Free Protection for Hearing Aids
Protection requirements for hearing aids are becoming more complex, driven by tighter global regulation and rising expectations around device reliability. Over the past year, we placed particular focus on supporting manufacturers through this transition with our long-established, PFOA-free and PFAS-free molecular coating solutions. With major regulatory deadlines now in force, including the end of PFOA exemptions for medical devices entering the EU, our coatings offer a fast, compliant, and high-performance alternative to traditional seals and legacy coatings, chosen not just for compliance but for the reliability, reduced returns, and improved consumer confidence they deliver. Learn more.
Expanding Our Presence in India
This year also saw the start of an important new partnership in India. Working closely with our customer, we’ve already helped deliver stronger reliability and lower failure rates by integrating our molecular technology into their production processes. It’s early days, but the results have been very encouraging. India is a strategic growth region for us, and we’re excited to deepen our presence there as we move forward.
Thank you to all of our customers, colleagues, and stakeholders for your support throughout the year. In the year ahead, we look forward to becoming further established in India, entering new territories, and strengthening our position across global markets. We’re proud of what 2025 has delivered – and even more excited for what 2026 will bring.